Wiercinska, E.
Quade-Lyssy, P. http://orcid.org/0009-0008-8128-6309
Hümmer, C.
Beifuß, J.
Akarkach, K.
Poppe, C.
Olevska, V.
Dzionek, J.
Lahnor, H.
Bosio, A.
Papanikolaou, E.
Bonig, Halvard
Funding for this research was provided by:
Miltenyi Biotec
Johann Wolfgang Goethe-Universität, Frankfurt am Main
Article History
Received: 15 September 2023
Accepted: 17 November 2023
First Online: 25 November 2023
Declarations
:
: Donors of mobilized apheresis product provided written informed consent to participate for research purposes, approved by the Ethics Committee of Goethe University Medical School, Frankfurt, Germany (approval number 286/13).
: Permission was obtained from Miltenyi Biotec B.V. & Co. KG for using the following images: 1. Prodigy illustration 2. CliniMACS Prodigy TS 320 setup for LP-TCRab-19-45RA Depletion.
: VO, JD, AB and EP are employees of Miltenyi Biotec B.V. & Co. KG, HL is an employee of Miltenyi Biomedicine GmbH, manufacturers of the technology described here. HB has received research funding and has served on the speaker’s bureau of Miltenyi Biotec B.V. & Co. KG. Studies were supported by in-kind contributions of Miltenyi Biotec B.V. & Co. KG. None of the other authors have conflicts to declare.